Role of 123I-Metaiodobenzylguanidine Myocardial Scintigraphy in Parkinsonian Disorders
None
Saved in:
Main Author: | Suzuki, Masahiko |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
IntechOpen
2012
|
Subjects: | |
Online Access: | https://www.intechopen.com/chapters/27869 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Standardization of 123I-metaiodobenzylguanidine cardiac neurotropic scintigraphy and single-photon emission tomography
by: A. A. Ansheles, et al.
Published: (2016-07-01) -
The Prognostic Value of the Results of <sup>123</sup>I-metaiodobenzylguanidine Myocardial Scintigraphy in the Examination of Patients with Atrial Fibrillation Referred for Its Interventional Treatment
by: Yu. V. Varlamova, et al.
Published: (2019-11-01) -
Dystonia in Parkinsonian Syndromes
by: Lugo, Ramon, et al.
Published: (2012) -
Relevance of Aerodynamic Evaluation in Parkinsonian Dysarthria
by: Moustapha, Sarr Mamadou, et al.
Published: (2011) -
Myocardial Perfusion Scintigraphy in Ischemic Heart Disease
by: Sonia María Sánchez Valcarcel, et al.
Published: (2021-09-01)